Primary sources document Dr. Saul Hertz (1905 -1950 as conceiving and developing radioiodine (RAI) as a diagnostic tool and as a therapy for thyroid diseases. Dr. Hertz was the irst and foremost person to develop the experimental data on RAI and apply it to the clinical setting.
Saul Hertz was born on April 20,1905 MGH's Chief of Medicine and founder of The MGH Thyroid Unit, con irms that Dr. Hertz solely and spontaneously asked MIT President Compton the pivotal question, in his letter to the Markle Foundation that funded the building of the MIT Cyclotron. Dr. Means stated, "Our primary interest was in iodine metabolism and when it became apparent that there might be a radioactive isotope of iodine, it at once occurred to Hertz that we might make use of them to solve a problem we were already working on."
A collaboration was established between MGH's Dr. Hertz and MIT physicist, Dr. Arthur Roberts. In late 1937, animal studies involving 48 rabbits demonstrated that the normal thyroid gland concentrated Iodine 128, and the hyperplastic thyroid gland took up even more Iodine. Physicist Arthur Roberts created non cyclotron I-128 based on Enrico Fermi's work. When the paper reporting their results was ready for publication, MIT's lab director, Robley Evans, insisted his name be added an author as it was a condition of Arthur Roberts's employment. Hertz and Roberts had designed and executed the animal studies, analyzed the data and wrote the paper. Robley Evans had not participated. Evans dictated a letter to the publisher that Hertz had to sign, so Robley Evan's name was added to this benchmark paper having taken no part in the actual research. Dr. Hertz's use of radioactive iodine as a tracer in the diagnostic process, as a treatment for Graves' disease and in the treatment of cancer revolutionized the treatment of thyroid diseases. He overcame the racism of his time, institutional politics, unethical publishing practices and a world war interrupting his clinical trials to bring his work to fruition. Dr. Hertz left a profound and enduring legacy by prolonging the lives of countless generations of patients, integrating the sciences in the quest to conquer cancer and providing the foundation of precision medicine. Hertz's breakthrough research changed the paradigm with the establishment of collaborative teams. Let us be thankful to Saul Hertz and for all those who have carried his dream forward.
